跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 58 条关于
“Baili Tianheng”
全部
58
临床试验
23
药物
18
机构
7
资讯
10
去年
Baili Tianheng's BL-B01D1 Shows Promise in Multiple Phase III Trials
去年
Baili Tianheng's Novel Bispecific ADC Receives Fifth Breakthrough Therapy Designation for Small Cell Lung Cancer
2个月前
China's Pharma Industry Charts Innovation-Driven Future at Landmark Beijing Conference
14天前
CAR-T Therapies Vie for Historic First Inclusion in China's Basic Medical Insurance Catalog
7个月前
CD137 Targeted Therapies Advance with 90 Clinical Trials Spanning Multiple Cancer Types
去年
Robust Pipeline for Nasopharyngeal Cancer Treatment Emerges with 25+ Pharmaceutical Companies Developing Novel Therapies
2年前
Antibody-Drug Conjugates for Cancer Show Promise with Multiple FDA Approvals Anticipated by 2027
去年
Tetraspecific Antibodies Poised for First FDA Approval by 2029, Market Report Reveals
2年前
Bispecific Antibody-Drug Conjugates Show Promise in Solid Tumor Treatment
去年
Biocytogen and Nanjing Chia Tai Tianqing Receive IND Approval for Second-Generation Anti-IGF-1R Antibody NTB003 in Thyroid Eye Disease